Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-22-001626
Filing Date
2022-02-02
Accepted
2022-02-02 07:26:50
Documents
27
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 6-K remunerationreport2021.htm 6-K 82040
2 remunerationreport2021001.jpg GRAPHIC 65767
3 remunerationreport2021002.jpg GRAPHIC 174958
4 remunerationreport2021003.jpg GRAPHIC 107476
5 remunerationreport2021004.jpg GRAPHIC 222872
6 remunerationreport2021005.jpg GRAPHIC 231003
7 remunerationreport2021006.jpg GRAPHIC 67619
8 remunerationreport2021007.jpg GRAPHIC 178568
9 remunerationreport2021008.jpg GRAPHIC 168943
10 remunerationreport2021009.jpg GRAPHIC 61682
11 remunerationreport2021010.jpg GRAPHIC 139851
12 remunerationreport2021011.jpg GRAPHIC 259892
13 remunerationreport2021012.jpg GRAPHIC 143411
14 remunerationreport2021013.jpg GRAPHIC 125859
15 remunerationreport2021014.jpg GRAPHIC 151380
16 remunerationreport2021015.jpg GRAPHIC 139101
17 remunerationreport2021016.jpg GRAPHIC 138311
18 remunerationreport2021017.jpg GRAPHIC 199333
19 remunerationreport2021018.jpg GRAPHIC 153898
20 remunerationreport2021019.jpg GRAPHIC 112245
21 remunerationreport2021020.jpg GRAPHIC 132173
22 remunerationreport2021021.jpg GRAPHIC 141981
23 remunerationreport2021022.jpg GRAPHIC 189166
24 remunerationreport2021023.jpg GRAPHIC 76892
25 remunerationreport2021024.jpg GRAPHIC 161740
26 remunerationreport2021025.jpg GRAPHIC 30422
27 remunerationreport2021026.jpg GRAPHIC 36798
  Complete submission text file 0001628280-22-001626.txt   5059649
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-82318 | Film No.: 22581541
SIC: 2834 Pharmaceutical Preparations